Quitting cigarettes may not improve smokers' lung function if they have already begun to develop chronic obstructive pulmonary disease, according to new research from Weill Cornell Medicine.
An enzyme that stimulates the breakdown of fats in immune cells helps trigger inflammation, or an immune response to pathogens, a new study by Weill Cornell Medicine researchers suggests.
Nurturing creativity in science will be explored on July 25 by leading scientists, including two Nobel Prize winners, at the Creativity Spark: a creativity workshop for scientists.
Gilbert Stoewsand, a Cornell food scientist who helped to rescue New York's fledgling wine industry in the early 1970s by debunking shoddy science that attributed health risks wine made from hybrid grapes, died July 4. He was 83.
Rodney Dietert, Cornell professor of immunotoxicology, has penned a new book that calls for a new paradigm in how we view public health and human biology.
The key to curing multiple sclerosis may well lie in the mysterious signaling of lipids, a major component of cells, says Cornell chemist Jeremy Baskin.
Cornell researchers have helped develop a recellularized human colon model that could be used to track the pathogenesis of colon cancer and possibly gain insight into its spread to other organs.
The grant, awarded to four New York City medical centers, including Weill Cornell Medicine, aims to improve physicians' ability to prevent and treat disease based on individual differences in lifestyle, environment and genetics.
Three pairs of early career scientists have been named the inaugural Mong Family Foundation Fellows in Neurotech. They will work jointly under the mentorship of faculty across Cornell to advance brain technologies.
